SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    María Chaparro, Javier P Gisbert, How safe is infliximab therapy during pregnancy and lactation in inflammatory bowel disease?, Expert Opinion on Drug Safety, 2014, 13, 12, 1749

    CrossRef

  2. 2
    Javier P Gisbert, María Chaparro, Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease, The American Journal of Gastroenterology, 2013, 108, 9, 1426

    CrossRef

  3. You have free access to this content3
    F. M. Habal, V. W. Huang, Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient, Alimentary Pharmacology & Therapeutics, 2012, 35, 5
  4. 4
    Nada Djokanovic, Chagit Klieger-Grossmann, Anna Pupco, Gideon Koren, Safety of infliximab use during pregnancy, Reproductive Toxicology, 2011, 32, 1, 93

    CrossRef

  5. 5
    Thao Pham, Hervé Bachelez, Jean-Marie Berthelot, Jacques Blacher, Yoram Bouhnik, Pascal Claudepierre, Arnaud Constantin, Bruno Fautrel, Philippe Gaudin, Vincent Goëb, Laure Gossec, Philippe Goupille, Séverine Guillaume-Czitrom, Eric Hachulla, Isabelle Huet, Denis Jullien, Odile Launay, Marc Lemann, Jean-Francis Maillefert, Jean-Pierre Marolleau, Valérie Martinez, Charles Masson, Jacques Morel, Luc Mouthon, Stanislas Pol, Xavier Puéchal, Pascal Richette, Alain Saraux, Thierry Schaeverbeke, Martin Soubrier, Anne Sudre, Tu-Anh Tran, Manuelle Viguier, Olivier Vittecoq, Daniel Wendling, Xavier Mariette, Jean Sibilia, TNF alpha antagonist therapy and safety monitoring, Joint Bone Spine, 2011, 78, 15

    CrossRef

  6. 6
    W. Miehsler, G. Novacek, H. Wenzl, H. Vogelsang, P. Knoflach, A. Kaser, C. Dejaco, W. Petritsch, M. Kapitan, H. Maier, W. Graninger, H. Tilg, W. Reinisch, A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease, Journal of Crohn's and Colitis, 2010, 4, 3, 221

    CrossRef

  7. 7
    F. Bachmann, A. Nast, W. Sterry, S. Philipp, Safety and Efficacy of the Tumor Necrosis Factor Antagonists, Seminars in Cutaneous Medicine and Surgery, 2010, 29, 1, 35

    CrossRef

  8. 8
    Javier P. Gisbert, Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding, Inflammatory Bowel Diseases, 2010, 16, 5
  9. 9
    Melissa Munsell, Marc Sonenshine, Mary L. Harris, Principles of Gender-Specific Medicine, 2010,

    CrossRef

  10. 10
    Evelyne Vinet, Christian Pineau, Caroline Gordon, Ann E Clarke, Sasha Bernatsky, Anti-TNF therapy and pregnancy outcomes in women with inflammatory arthritis, Expert Review of Clinical Immunology, 2009, 5, 1, 27

    CrossRef

  11. 11
    Evelyne Vinet, Christian Pineau, Caroline Gordon, Ann E. Clarke, Sasha Bernatsky, Biologic therapy and pregnancy outcomes in women with rheumatic diseases, Arthritis Care & Research, 2009, 61, 5
  12. 12
    Jean-Marie Berthelot, Michel De Bandt, Philippe Goupille, Elisabeth Solau-Gervais, Frédéric Lioté, Vincent Goeb, Isabelle Azaïs, Antoine Martin, Béatrice Pallot-Prades, Yves Maugars, Xavier Mariette, Exposition aux anti-TNF pendant la grossesse : devenir de 15 cas et revue de la littérature, Revue du Rhumatisme, 2009, 76, 1, 32

    CrossRef

  13. 13
    Jean-Marie Berthelot, Michel De Bandt, Philippe Goupille, Elisabeth Solau-Gervais, Frédéric Lioté, Vincent Goeb, Isabelle Azaïs, Antoine Martin, Béatrice Pallot-Prades, Yves Maugars, Xavier Mariette, Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature, Joint Bone Spine, 2009, 76, 1, 28

    CrossRef

  14. 14
    Alfredo Papa, Giammarco Mocci, Michele Bonizzi, Carla Felice, Gianluca Andrisani, Italo De Vitis, Luisa Guidi, Antonio Gasbarrini, Use of Infliximab in Particular Clinical Settings: Management Based on Current Evidence, The American Journal of Gastroenterology, 2009, 104, 6, 1575

    CrossRef

  15. 15
    Sang-Heon Lee, Use of TNF Inhibitor in Particular Clinical Settings, The Journal of the Korean Rheumatism Association, 2009, 16, 4, 264

    CrossRef

  16. 16
    Marla Dubinsky, Bincy Abraham, Uma Mahadevan, Management of the pregnant IBD patient, Inflammatory Bowel Diseases, 2008, 14, 12
  17. 17
    S. O'DONNELL, C. O'MORAIN, Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception, Alimentary Pharmacology & Therapeutics, 2008, 27, 10
  18. 18
    Christian Mottet, Pascal Juillerat, Valérie Pittet, Jean-Jacques Gonvers, Florian Froehlich, John-Paul Vader, Pierre Michetti, Christian Felley, Pregnancy and Breastfeeding in Patients with Crohn’s Disease, Digestion, 2007, 76, 2, 149

    CrossRef

  19. 19
    Alice A Robinson, William J Watson, Kimberly K Leslie, Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitors in pregnancy, The Lancet Oncology, 2007, 8, 8, 738

    CrossRef

  20. You have free access to this content20
    Kyung-Su PARK, Sung-Hwan PARK, Adverse effects of tumour necrosis factor-α blocking agents, APLAR Journal of Rheumatology, 2006, 9, 2
  21. 21
    Uma Mahadevan, Sunanda Kane, American Gastroenterological Association Institute Technical Review on the Use of Gastrointestinal Medications in Pregnancy, Gastroenterology, 2006, 131, 1, 283

    CrossRef

  22. 22
    M. de Bandt, Traitements rhumatologiques autorisés au cours de la grossesse et de l'allaitement, EMC - Traité de médecine AKOS, 2006, 1, 2, 1

    CrossRef

  23. 23
    M. de Bandt, Tratamientos reumatológicos autorizados durante la gestación y la lactancia, EMC - Tratado de Medicina, 2006, 10, 3, 1

    CrossRef

  24. 24
    3 Clinical situation: Management in the case of pregnancy?, Joint Bone Spine, 2005, 72, S51

    CrossRef

  25. 25
    Katherine K. Temprano, Rama Bandlamudi, Terry L. Moore, Antirheumatic Drugs in Pregnancy and Lactation, Seminars in Arthritis and Rheumatism, 2005, 35, 2, 112

    CrossRef

  26. 26
    U. Mahadevan, S. Kane, W. J. Sandborn, R. D. Cohen, K. Hanson, J. P. Terdiman, D. G. Binion, Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease, Alimentary Pharmacology & Therapeutics, 2005, 21, 6
  27. 27
    Frédéric Lioté, Médicaments rhumatologiques autorisés pendant la grossesse, Revue du Rhumatisme, 2005, 72, 8, 755

    CrossRef

  28. 28
    Christian Mottet, Pascal Juillerat, Jean-Jacques Gonvers, Florian Froehlich, Bernard Burnand, John-Paul Vader, Pierre Michetti, Christian Felley, Pregnancy and Crohn’s Disease, Digestion, 2005, 71, 1, 54

    CrossRef

  29. 29
    J. Ledingham, C. Deighton, Update on the British Society for Rheumatology guidelines for prescribing TNF  blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001), Rheumatology, 2005, 44, 2, 157

    CrossRef

  30. 30
    Thierry Vial, Jacques Descotes, Felix Braun, Matthias Behrend, 2005,

    CrossRef

  31. 31
    Dinesh Khanna, Maureen McMahon, Daniel E Furst, Safety of Tumour Necrosis Factor-?? Antagonists, Drug Safety, 2004, 27, 5, 307

    CrossRef

  32. 32
    Costanza Cocilovo, Toyooki Sonoda, Jeffrey W. Milsom, Principles of Gender-Specific Medicine, 2004,

    CrossRef

  33. 33
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2003, 12, 6